CM
CNTA

Caption Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Caption Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318K Sell
8,000
-130,800
-94% -$3.35M ﹤0.01% 1289
2025
Q4 		$3.47M Sell
138,800
-191,800
-58% -$4.86M 0.02% 630
2025
Q3 		$8.02M Buy
330,600
+301,000
+1,017% +$5.35M 0.06% 339
2025
Q2 		$389K Buy
29,600
+13,700
+86% +$174K ﹤0.01% 1170
2025
Q1 		$229K Buy
+15,900
New +$260K ﹤0.01% 1248

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Caption Management's CNTA Position: Q1 2026 in Review

Caption Management opened a new position in Centessa Pharmaceuticals (CNTA) in Q1 2026: 274,116 shares worth $10.9M. The stake represents 0.06% of the portfolio and ranks #307 among its holdings. This is a return to the name: Caption Management previously reported a position in CNTA as recently as Q3 2025.

Caption Management first reported a position in CNTA in Q1 2025 and has held it in 3 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Caption Management held 274,116 shares of Centessa Pharmaceuticals worth $10.9M as of Q1 2026.
  • Centessa Pharmaceuticals was a new Caption Management position in Q1 2026.
  • Centessa Pharmaceuticals made up 0.06% of Caption Management's portfolio in Q1 2026, its #307 holding.
  • Caption Management first reported a position in Centessa Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.